Table 3.
Guttate psoriasis (n = 32) median (IQR), mean |
Plaque psoriasis (n = 42) median (IQR), mean |
P a | |
---|---|---|---|
IL-1RA (pg/mL) | 2.75 (1.12–7.18), 4.84 | 1.20 (0.00–5.21), 4.06 | 0.229 |
IL-2 (pg/mL) | 0.81 (0.70–1.31), 0.11 | 0.84 (0.59–1.14), 1.00 | 0.558 |
IL-12 (pg/mL) | 0.00 (0.00–4.80), 2.75 | 2.71 (0.00–5.91), 3.61 | 0.320 |
IL-17A (pg/mL) | 0.00 (0.00–1.23), 1.31 | 0.68 (0.00–1.54), 1.80 | 0.580 |
IL-22 (pg/mL) | 0.10 (0.09–0.14), 0.14 | 0.11 (0.09–0.20), 0.15 | 0.443 |
IL-23 (pg/mL) | 1.57 (1.44–1.86), 2.01 | 1.58 (1.44–2.03), 1.97 | 0.756 |
IFN-γ (pg/mL) | 2.90 (2.62–5.00), 4.64 | 3.02 (2.46–5.18), 4.45 | 0.768 |
LL-37 (ng/mL) | 10.95 (8.96–16.94), 13.20 | 12.56 (10.60–16.90), 13.65 | 0.204 |
aMann-Whitney U test between patients with guttate psoriasis and plaque psoriasis.